# A Study of Human Substance Balance and Biotransformation of [14C]SHR0302

> **NCT05047341** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Rheumatoid Arthritis (RA)

## Interventions

- **DRUG:** SHR0302、[14C]SHR0302

## Key facts

- **NCT ID:** NCT05047341
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-07
- **Primary completion:** 2021-09-19
- **Final completion:** 2022-06-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05047341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05047341, "A Study of Human Substance Balance and Biotransformation of [14C]SHR0302". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05047341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*